Literature DB >> 4560806

Human toxoplasmosis prevalence and exposure to cats.

D R Peterson, E Tronca, P Bonin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4560806     DOI: 10.1093/oxfordjournals.aje.a121450

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  12 in total

1.  Toxoplasmosis in veterinarians: an investigation into possible sources of infection.

Authors:  I R Tizard; F A Caoili
Journal:  Can Vet J       Date:  1976-01       Impact factor: 1.008

2.  Prevalence of Toxoplasma gondii antibodies in gravidas and recently aborted women and study of risk factors.

Authors:  G Decavalas; M Papapetropoulou; E Giannoulaki; V Tzigounis; X G Kondakis
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

3.  Toxoplasma gondii: parasitology and transmission.

Authors:  L Jacobs
Journal:  Bull N Y Acad Med       Date:  1974-02

Review 4.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

5.  Breaking the transmission chain of Toxoplasma: a program for the prevention of human toxoplasmosis.

Authors:  J K Frenkel
Journal:  Bull N Y Acad Med       Date:  1974-02

6.  Dogs and transmission of toxoplasmosis.

Authors:  M B Markus; M B Marcus
Journal:  Br Med J       Date:  1973-06-16

7.  The seroepidemiology of toxoplasmosis in the lower Fraser Valley of British Columbia.

Authors:  E M Proctor; S N Banerjee
Journal:  Can J Infect Dis       Date:  1994-09

8.  Prevalence of Toxoplasma gondii antibodies among veterinary college staff and students, Iowa State University.

Authors: 
Journal:  Public Health Rep       Date:  1976 Nov-Dec       Impact factor: 2.792

9.  Aetiology of human toxoplasmosis.

Authors:  P M Hendy-Ibbs
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

10.  Congenital ocular toxoplasmosis.

Authors:  D D Perry; J C Merritt
Journal:  J Natl Med Assoc       Date:  1983-02       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.